piroximone has been researched along with iloprost in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buerke, M; Darius, H; Dieterich, HA; Meyer, J | 1 |
| Heintz, B; Kirsten, D; Kirsten, R; Nelson, K | 1 |
1 review(s) available for piroximone and iloprost
| Article | Year |
|---|---|
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents | 1998 |
1 other study(ies) available for piroximone and iloprost
| Article | Year |
|---|---|
Synergistic platelet inhibitory effect of the phosphodiesterase inhibitor piroximone and iloprost.
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Animals; Collagen; Cyclic AMP; Drug Synergism; Enzyme Activation; Humans; Iloprost; Imidazoles; In Vitro Techniques; Male; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Rats; Rats, Inbred Strains | 1992 |